盐霉素
假中间葡萄球菌
微生物学
抗菌剂
肉汤微量稀释
金黄色葡萄球菌
拉沙酸
葡萄球菌
耐甲氧西林金黄色葡萄球菌
药效学
莫能星
生物
最小抑制浓度
抗生素
细菌
药理学
药代动力学
生物化学
遗传学
离子载体
膜
作者
Elizabeth E. Hickey,Stephen W. Page,Darren J. Trott
摘要
Abstract The objective of this study was to determine the minimum inhibitory concentrations (MICs) and pharmacodynamic profiles of four ionophores (lasalocid, monensin, narasin and salinomycin) against staphylococcal isolates from clinical cases of human and veterinary staphylococcal infections, and to determine the effect of methicillin resistance on the antimicrobial activity of ionophores. Broth microdilution MIC testing was used to determine antimicrobial activity against 156 staphylococcal isolates of human and veterinary origin. Pharmacodynamic profiles were examined using time‐kill kinetics profiles against an ATCC type strain of Staphylococcus aureus and a clinical isolate of methicillin‐resistant Staphylococcus pseudintermedius . All tests were performed in accordance with CLSI guidelines. All four ionophores demonstrated antimicrobial activity against methicillin‐resistant staphylococci at concentrations similar to those observed for methicillin‐susceptible isolates of the same species. Testing of human and veterinary MRSA isolates also showed that MIC values were not influenced by the host origin of the isolates. Pharmacodynamic profiles were similar for both isolates tested across all four ionophores, with similar reductions in viable cell counts being observed over an 18‐ to 24‐hr period. Lasalocid, monensin, narasin and salinomycin all demonstrated antimicrobial activity against staphylococcal isolates of human and veterinary origins, with activity being unaffected by methicillin resistance status, although some Staphylococcus species‐specific effects were observed that require further investigation.
科研通智能强力驱动
Strongly Powered by AbleSci AI